Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/31/22
Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022GlobeNewsWire • 05/16/22
Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/22/22
Burning Rock to Release MRD Clinical Data on NSCLC and CRC at the Upcoming American Association for Cancer Research Annual MeetingGlobeNewsWire • 03/15/22
Burning Rock Schedules Fourth Quarter and Full Year 2021 Earnings Release on March 22, 2022GlobeNewsWire • 02/22/22
Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Liquid-biopsy Based CDx Development Using Burning Rock's OncoCompass Target™GlobeNewsWire • 11/18/21
Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/16/21
Burning Rock Announces 2021 Annual General Meeting to be Held on December 28, 2021GlobeNewsWire • 11/16/21
Burning Rock Collaborates with IMPACT Therapeutics to Provide Testing Services in Developing IMP9064 in both US and ChinaGlobeNewsWire • 11/04/21
Burning Rock Schedules Third Quarter of 2021 Earnings Release on November 16, 2021GlobeNewsWire • 11/03/21
Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/31/21
Burning Rock and IMPACT Therapeutics Announce a Global Strategic Partnership for Companion Diagnostics DevelopmentGlobeNewsWire • 08/03/21
Burning Rock Schedules Second Quarter of 2021 Earnings Release on August 31, 2021GlobeNewsWire • 08/02/21